How should I evaluate and manage bilateral hand swelling?

Evaluation and Management of Bilateral Hand Swelling

Begin with clinical examination to detect joint swelling (synovitis), which is the cornerstone of diagnosis and should focus on identifying inflammatory arthritis patterns, particularly symmetric involvement of metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints. 1, 2

Initial Clinical Assessment

Key History Elements

• Duration of symptoms: Morning stiffness lasting >30 minutes to 1 hour suggests inflammatory arthritis 3, 4
• Pattern of joint involvement: Symmetric polyarthritis affecting hands and feet, particularly MCP and PIP joints, is characteristic of rheumatoid arthritis 1, 5
• Functional impact: Assess limitations in activities of daily living and work capacity 4
• Associated symptoms: Joint pain that improves with NSAIDs or corticosteroids (not opioids) suggests inflammatory etiology 3

Physical Examination Specifics

• Perform "squeeze test" of MCP and metatarsophalangeal joints to detect tenderness 1
• Document number and distribution of tender and swollen joints bilaterally 4
• Examine for extra-articular features: subcutaneous nodules, skin changes, nail pitting 6
• Assess for dactylitis ("sausage digits") which may indicate psoriatic arthritis 6

Differential Diagnosis Considerations

All possible causes must be considered: idiopathic, autoimmune (rheumatoid arthritis, psoriatic arthritis), infectious, malignancy, traumatic, metabolic, and dermatologic conditions 4

Specific Conditions to Exclude

• Inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis): Look for symmetric joint swelling with morning stiffness 3, 1
• Contact dermatitis (irritant or allergic): Consider if history includes frequent hand washing, occupational exposures, or use of soaps/sanitizers 7
• Infection: Rule out septic arthritis, particularly in monoarthritis 4
• Immune checkpoint inhibitor-related arthritis: If patient is on cancer immunotherapy 8, 3

Initial Laboratory Testing

Order the following baseline tests 1, 4:

• Complete blood count
• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for inflammatory markers 4
• Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) - both are predictive of rheumatoid arthritis diagnosis and prognosis 4, 2
• Urinalysis
• Transaminases
• Antinuclear antibodies (ANA) to screen for connective tissue diseases 1

Imaging Strategy

First-Line Imaging

Obtain plain radiographs of both hands and wrists (posteroanterior, lateral, and oblique views) as the initial imaging study 9

• Assess for erosions, joint space narrowing, soft tissue swelling, and alignment abnormalities 9
• Presence of erosions is highly predictive of persistent and erosive disease 1, 2
• Repeat radiographs within 1 year if initial films are normal but clinical suspicion remains 1

Advanced Imaging Indications

Consider ultrasonography with power Doppler to confirm synovitis when clinical examination is equivocal 2

• US can detect synovitis, tenosynovitis, and early erosions with higher sensitivity than clinical examination 2, 10

MRI of bilateral hands and wrists should be considered when 2, 11, 10:

• Diagnosis remains uncertain after clinical and US evaluation
• Early detection of bone marrow edema and erosions is needed for prognostic assessment
• Bilateral imaging is essential as MRI findings are often asymmetric; unilateral scanning risks missing 16-23% of erosions and osteitis 11
• Include PIP joints in the MRI protocol, as 87% of early RA patients show synovitis and 69% show tenosynovitis in these joints 11

Management Based on Etiology

If Inflammatory Arthritis is Suspected

Refer to rheumatology within 6 weeks of symptom onset 1

For Confirmed or Probable Rheumatoid Arthritis

• Grade 1 (mild pain with inflammation): Continue monitoring, initiate NSAIDs (naproxen 500 mg BID or meloxicam 7.5-15 mg daily) 8, 3
• Grade 2 (moderate pain limiting instrumental ADL): Hold immunotherapy if applicable; consider prednisone 10-20 mg daily for 2-4 weeks 8, 3
• Grade 3-4 (severe pain, irreversible damage): Initiate prednisone 0.5-1 mg/kg daily; consider disease-modifying antirheumatic drugs (DMARDs) or biologic therapy in consultation with rheumatology 3

If Contact Dermatitis is Suspected

For irritant contact dermatitis 7:

• Identify and avoid irritants (frequent hand washing, hot water, harsh soaps)
• Apply moisturizer immediately after hand washing using minimum 2 fingertip units per hand 7
• Use lukewarm water and fragrance-free, dye-free synthetic detergents with added moisturizers 7
• Apply topical corticosteroids if conservative measures fail 7

For allergic contact dermatitis 7:

• Refer for patch testing to identify specific allergens 7
• Avoid identified allergens
• For glove-related ACD, use accelerator-free neoprene or nitrile gloves 7
• Apply topical steroids for acute flares 7

Critical Pitfalls to Avoid

• Do not delay rheumatology referral beyond 6 weeks if inflammatory arthritis is suspected, as early treatment improves outcomes 1, 5
• Do not perform unilateral imaging when inflammatory arthritis is suspected; bilateral assessment is essential due to asymmetric disease patterns 11
• Do not overlook PIP joint involvement in imaging protocols for suspected early RA 11
• Do not use intra-articular corticosteroids in early inflammatory arthritis before establishing diagnosis and initiating systemic therapy 12
• Do not assume hand dermatitis is benign; recalcitrant cases require dermatology consultation and patch testing 7

Follow-Up Monitoring

• Serial rheumatologic examinations every 4-6 weeks after treatment initiation for inflammatory arthritis 3
• Repeat inflammatory markers (ESR, CRP) when clinically relevant 4
• Document treatment response using objective measures of joint swelling and function 4